Annals of the Russian academy of medical sciencesAnnals of the Russian academy of medical sciences0869-60472414-3545"Paediatrician" Publishers LLC833410.15690/vramn8334Research ArticleEfficacy of catheter treatment of atrial fibrillation in patients with myocarditis depending on the adrenoreaction of the body (a prospective single-center study)ArchakovEvgenii A.<p>MD, PhD</p>aea_cardio@mail.ruhttps://orcid.org/0000-0002-2530-361XBatalovRoman E.<p>MD, PhD</p>romancer@cardio-tomsk.ruhttps://orcid.org/0000-0003-1415-3932EshmatovOtabek R.atabek_eshmatov@mail.ruhttps://orcid.org/0000-0003-4075-052XStepanovIvan V.<p>MD, PhD</p>i_v_stepanov@mail.ruhttps://orcid.org/0000-0002-8543-6027MuslimovaElvira F.<p>MD, PhD</p>muslimovef@yandex.ruhttps://orcid.org/0000-0001-7361-2161RebrovaTatyana U.<p>MD, PhD</p>rebrova@yandex.ruhttps://orcid.org/0000-0003-3667-9599AfanasyevSergey A.<p>MD, PhD, Professor</p>tursky@cardio-tomsk.ruhttps://orcid.org/0000-0001-6066-3998PopovSergey V.<p>MD, PhD, Professor, Academican of the RAS</p>psv@cardio-tomsk.ruhttps://orcid.org/0000-0002-9050-4493Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences240520237821511590703202328042023Copyright © 2023, "Paediatrician" Publishers LLC2023<p><strong><em>Background. </em></strong><em>Worldwide, research continues into various factors that may influence the success of catheter treatment of atrial fibrillation. In this regard, the influence of the state of the sympathoadrenal system of the body has not been studied enough. <strong>Aims</strong> to evaluate the effectiveness of interventional treatment of atrial fibrillation (AF) in patients with and without myocarditis, depending on the level of beta-adrenergic responsiveness of the organism.<strong> Materials and methods.</strong> The study sample included 40 patients. Of these, 27 (67.5%) are men. The age in the sample was 49 (44; 55) years. The study included 25 (62.5%) patients with paroxysmal AF, 10 (25.0%) with persistent and 5 (12.5%) with long-term persistent. All patients underwent surgical treatment of AF using radiofrequency (RFA) or cryoablation (CBA). Endomyocardial biopsy was performed in 18 patients to verify the diagnosis. Beta-adrenergic responsiveness (beta-ARM) was assessed in dynamics 3 days after surgery, 3 months and 12 months. The follow-up period for patients was 12 months.<strong> Results.</strong> All patients underwent surgical treatment of AF, in 7 cases (17.5%) CBA of the pulmonary veins was performed, in 33 (82.5%) cases RFA was performed. According to the biopsy results, signs of myocarditis were detected in 9 patients (22.5%). Focal myocarditis was found in 7 patients, diffuse in 2. The effectiveness of catheter treatment in general was 72.5%, for CBA 71.5%, for RFA 73.5%. Beta-ARM before ablation was 19.16% [12.46; 27.46], 3 days after ablation 24.43% [15.38; 33.65], after 3 months was 20.27% [9.90; 27.71], in 4 patients after 12 months, beta-ARM was 32.5% [20.0; 43.2]. The dynamics and influence of beta-ARM on the effectiveness of interventional treatment of AF in patients with early and late relapses, the presence of myocarditis was assessed. <strong>Conclusions. </strong>The results obtained showed no effect of the level of beta-ARM on the effectiveness of RFA and CBA in patients with and without myocarditis. Beta-ARM showed no association with the development of early arrhythmia recurrences after ablation. No statistically significant differences were found when comparing beta-ARM levels in patients with and without diagnosed myocarditis.</em></p>atrial fibrillationmyocarditismembrane beta-adrenergic reactivityфибрилляция предсердиймиокардитбета-адренореактивность мембран[Киргизова М.А., Баталов Р.Е., Татарский Б.А., Попов С.В. Фибрилляция предсердий и артериальная гипертензия: современное представление о патогенезе, диагностике и лечении // Сибирский журнал клинической и экспериментальной медицины. — 2019. — Т. 34. — № 3. — С. 13–20. doi: https://doi.org/10.29001/2073-8552-2019-34-3-13-20 [Kirgizova MA, Batalov RE, Tatarsky BA, Popov SV. Atrial fibrillation and arterial hypertension: current understanding of pathogenesis, diagnosis and treatment. Siberian Journal of Clinical and Experimental Medicine. 2019;34(3):13–20. (In Russ.)] doi: https://doi.org/10.29001/2073-8552-2019-34-3-13-20][Muslimova E, Rebrova T, Kondratieva D, et al. Expression of the β1-adrenergic receptor (ADRB1) gene in the myocardium and β-adrenergic reactivity of the body in patients with a history of myocardium infraction. Gene. 2022;844:146820. doi: https://doi.org/10.1016/j.gene.2022.146820][Maisch B, Bültman B, Factor S, et al. World Heart Federation consensus conferences definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy. Heartbeat. 1999;4:3–4.][Basso C, Calabrese F, Angelini A, et al. Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease. Heart Fail Rev. 2013;18(6):673–681. doi: https://doi.org/10.1007/s10741-012-9355-6][Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636–2648. doi: https://doi.org/10.1093/eurheartj/eht210][Mitrofanova LB, Orshanskaya V, Ho SY, Platonov PG. Histological evidence of inflammatory reaction associated with fibrosis in the atrial and ventricular walls in a case-control study of patients with history of atrial fibrillation. Europace. 2016;18(Suppl 4):iv156–iv162. doi: https://doi.org/10.1093/europace/euw361][Клинические рекомендации по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств. — М.: Новая редакция; 2017. — 701 с. [Klinicheskie rekomendatsii po provedeniyu elektrofiziologicheskikh issledovanii, kateternoi ablyatsii i primeneniyu implantiruemykh antiaritmicheskikh ustroistv. Moscow: Novaya redaktsiya; 2017. 701 p. (In Russ.)]][Pfleger J, Gresham K, Koch WJ. G protein-coupled receptor kinases as therapeutic targets in the heart. Nat Rev Cardiol. 2019;16(10):612–622. doi: https://doi.org/10.1038/s41569-019-0220-3][Mahmood A, Ahmed K, Zhang Y. β-Adrenergic Receptor Desensitization/Down-Regulation in Heart Failure: A Friend or Foe? Front Cardiovasc Med. 2022;9:925692. doi: https://doi.org/10.3389/fcvm.2022.925692]